Project Views
34
Appreciations
1
Followers
0
Following
0
Writing
As CEO and Vice Chairman of the Board of SELLAS Life Sciences Group, Angelos Stergiou works for effective drugs and immunotherapies to fight end-stage diseases in cancer. Dr. Angelos Stergiou’s background is in various medical initiatives, including biotechnology, cancer vaccines, immunotherapy, clinical research,… Read More
As CEO and Vice Chairman of the Board of SELLAS Life Sciences Group, Angelos Stergiou works for effective drugs and immunotherapies to fight end-stage diseases in cancer. Dr. Angelos Stergiou’s background is in various medical initiatives, including biotechnology, cancer vaccines, immunotherapy, clinical research, the access of the commercial market to biotechnological advances and the determination of pricing and reimbursement in pharmaceuticals, to name only a few. Read Less
Member since: